Your browser doesn't support javascript.
Prevalence of Coronavirus Disease 2019 Infection and Outcomes Among Symptomatic Healthcare Workers in Seattle, Washington.
Mani, Nandita S; Budak, Jehan Z; Lan, Kristine F; Bryson-Cahn, Chloe; Zelikoff, Allison; Barker, Gwendolyn E C; Grant, Carolyn W; Hart, Kristi; Barbee, Carrie J; Sandoval, Marissa D; Dostal, Christine L; Corcorran, Maria; Ungerleider, Hal M; Gates, Jeff O; Olin, Svaya V; Bryan, Andrew; Hoffman, Noah G; Marquis, Sara R; Harvey, Michelle L; Nasenbeny, Keri; Mertens, Kathleen; Chew, Lisa D; Greninger, Alexander L; Jerome, Keith R; Pottinger, Paul S; Dellit, Timothy H; Liu, Catherine; Pergam, Steven A; Neme, Santiago; Lynch, John B; Kim, H Nina; Cohen, Seth A.
  • Mani NS; Department of Medicine, School of Medicine, University of Washington, Seattle, Washington, USA.
  • Budak JZ; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Lan KF; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Bryson-Cahn C; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Zelikoff A; Population Health, Harborview Medical Center, Seattle, Washington, USA.
  • Barker GEC; Allied Ambulatory Care Services, Harborview Medical Center, Seattle, Washington, USA.
  • Grant CW; Patient Care Services, University of Washington Medical Center-Northwest, Seattle, Washington, USA.
  • Hart K; Patient Care Services, University of Washington Medical Center-Northwest, Seattle, Washington, USA.
  • Barbee CJ; Harborview Medical Center, Seattle, Washington, USA.
  • Sandoval MD; Harborview Medical Center, Seattle, Washington, USA.
  • Dostal CL; Harborview Medical Center, Seattle, Washington, USA.
  • Corcorran M; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Ungerleider HM; Respiratory Therapy, University of Washington Medical Center-Northwest, Seattle, Washington, USA.
  • Gates JO; Employee Health, University of Washington Medical Center-Northwest, Seattle, Washington, USA.
  • Olin SV; Infection Prevention and Control, University of Washington Medical Center-Northwest, Seattle, Washington, USA.
  • Bryan A; Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington, USA.
  • Hoffman NG; Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington, USA.
  • Marquis SR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Harvey ML; Clinical Trials Office, University of Washington, Seattle, Washington, USA.
  • Nasenbeny K; Patient Care Services, University of Washington Medical Center, Seattle, Washington, USA.
  • Mertens K; Primary Care and Population Health, Harborview Medical Center, Seattle, Washington, USA.
  • Chew LD; Division of General Internal Medicine, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Greninger AL; Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington, USA.
  • Jerome KR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Pottinger PS; Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington, USA.
  • Dellit TH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Liu C; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Pergam SA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Neme S; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Lynch JB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Kim HN; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Cohen SA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Clin Infect Dis ; 71(10): 2702-2707, 2020 12 17.
Article in English | MEDLINE | ID: covidwho-1059704
ABSTRACT

BACKGROUND:

Healthcare workers (HCWs) who serve on the front lines of the coronavirus disease 2019 (COVID-19) pandemic have been at increased risk for infection due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in some settings. Healthcare-acquired infection has been reported in similar epidemics, but there are limited data on the prevalence of COVID-19 among HCWs and their associated clinical outcomes in the United States.

METHODS:

We established 2 high-throughput employee testing centers in Seattle, Washington, with drive-through and walk-through options for symptomatic employees in the University of Washington Medicine system and its affiliated organizations. Using data from these testing centers, we report the prevalence of SARS-CoV-2 infection among symptomatic employees and describe the clinical characteristics and outcomes among employees with COVID-19.

RESULTS:

Between 12 March 2020 and 23 April 2020, 3477 symptomatic employees were tested for COVID-19 at 2 employee testing centers; 185 (5.3%) employees tested positive for COVID-19. The prevalence of SARS-CoV-2 was similar when comparing frontline HCWs (5.2%) with nonfrontline staff (5.5%). Among 174 positive employees reached for follow-up at least 14 days after diagnosis, 6 reported COVID-related hospitalization; all recovered.

CONCLUSIONS:

During the study period, we observed that the prevalence of positive SARS-CoV-2 tests among symptomatic HCWs was comparable to that of symptomatic nonfrontline staff. Reliable and rapid access to testing for employees is essential to preserve the health, safety, and availability of the healthcare workforce during this pandemic and to facilitate the rapid return of SARS-CoV-2-negative employees to work.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: Cid